Wesana Health Holdings Inc. (CSE: WESA | OTCQB: WSNAF), a data-driven life sciences company, today announced that Wesana Health Inc., a subsidiary of the Company, has received an unsecured short-term loan in an aggregate principal amount of US$250,000 from an arm’s length lender. The Loan will bear interest at a rate of 10% per annum, which interest will accrue and be payable upon maturity of the Loan. All principal and unpaid interest outstanding under the Loan will be due and payable nine months from the date of the Loan, provided that in certain circumstances such maturity date will be automatically extended to be one-year from the date of the Loan. The proceeds from the Loan are expected to be used by the Company for general corporate purposes.
ON BEHALF OF THE BOARD
Daniel Carcillo, Chairman and Chief Executive Officer
Phone: 702-329-8038
About Wesana Health
Wesana Health is a data-driven life science company pioneering drug development through its lead candidate SANA-013. Targeting Major Depressive Disorder as the lead indication, SANA-013 utilizes proprietary drug delivery protocols and a novel combination therapy. Wesana is composed of leaders from the scientific, research and medical industries driven by a common goal of improving the lives of millions of people globally suffering from mental health indications.